Dr. Peltz's wealth has been closely tied to PTC Therapeutics, where he held a notable stake. As of his retirement in March 2023, he held approximately 1.5 million shares and stock options. Over the years, his holdings experienced fluctuations, peaking...
Dr. Peltz's wealth has been closely tied to PTC Therapeutics, where he held a notable stake. As of his retirement in March 2023, he held approximately 1.5 million shares and stock options. Over the years, his holdings experienced fluctuations, peaking during significant company milestones. His stock value, particularly at the peak of PTC's progress, represented a considerable portion of his wealth. In 2020 alone, the total value of his holdings and other compensations was reported to be over $100 million, marking a pinnacle in his financial portfolio. After his retirement, his stock options and restricted shares will continue to vest based on the consulting agreement he has with PTC Therapeutics, illustrating a continued connection to the company's future success.